Thymomas and Thymic Carcinomas Clinical Practice Guidelines in Oncology

被引：65

作者：

Ettinger, David S. ^{[1
]}

Riely, Gregory J. ^{[2
]}

Akerley, Wallace ^{[3
]}

Borghaei, Hossein ^{[4
]}

Chang, Andrew C. ^{[5
]}

Cheney, Richard T. ^{[6
]}

Chirieac, Lucian R. ^{[7
]}

D'Amico, Thomas A. ^{[8
]}

Demmy, Todd L. ^{[6
]}

Govindan, Ramaswamy ^{[9
,10
]}

Grannis, Frederic W., Jr. ^{[11
]}

Grant, Stefan C. ^{[12
]}

Horn, Leora ^{[13
]}

Jahan, Thierry M. ^{[14
]}

Komaki, Ritsuko ^{[15
]}

Kong, Feng-Ming ^{[5
]}

Kris, Mark G. ^{[2
]}

Krug, Lee M. ^{[2
]}

Lackner, Rudy P. ^{[16
]}

Lennes, Inga T. ^{[17
]}

Loo, Billy W., Jr. ^{[18
]}

Martins, Renato ^{[19
,20
]}

Otterson, Gregory A. ^{[21
,22
]}

Patel, Jyoti D. ^{[23
]}

Pinder-Schenck, Mary C. ^{[24
]}

Pisters, Katherine M. ^{[15
]}

Reckamp, Karen ^{[11
]}

Rohren, Eric ^{[15
]}

Shapiro, Theresa A.

Swanson, Scott J. ^{[7
]}

Tauer, Kurt

Wood, Douglas E. ^{[19
,20
,25
]}

Yang, Stephen C. ^{[1
]}

Gregory, Kristina

Hughes, Miranda

机构：

[1] Sidney Kimmel Comprehens Canc Ctr Johns Hopkin, Baltimore, MD USA

[2] Mem Sloan Kettering Canc Ctr, New York, NY USA

[3] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA

[4] Fox Chase Canc Ctr, Philadelphia, PA USA

[5] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA

[6] Roswell Pk Canc Inst, Buffalo, NY USA

[7] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA

[8] Duke Canc Inst, Durham, NC USA

[9] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO USA

[10] Univ Washington, Sch Med, Seattle, WA 98195 USA

[11] City Hope Comprehens Canc Ctr, Duarte, CA USA

[12] Univ Alabama, Birmingham Comprehens Canc Ctr, Tuscaloosa, AL 35487 USA

[13] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[14] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA

[15] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[16] UNMC Eppley Canc Ctr, Nebraska Med Ctr, Omaha, NE USA

[17] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA

[18] Stanford Canc Inst, Stanford, CA USA

[19] Fred Hutchinson Canc Res Ctr, Seattle, WA USA

[20] Seattle Canc Care Alliance, Seattle, WA USA

[21] Ohio State Univ, Ctr Comprehens Canc, James Canc Hosp, Columbus, OH 43210 USA

[22] Solove Res Inst, Columbus, OH USA

[23] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA

[24] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[25] Univ Tennessee, Inst Canc, Knoxville, TN 37996 USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2013年 / 11卷 / 05期

关键词：

ADJUVANT RADIATION-THERAPY; PRIMARY MEDIASTINAL TUMORS; OF-THE-ART; EPITHELIAL TUMORS; PHASE-II; INVASIVE THYMOMA; STAGE-III; POSTOPERATIVE RADIOTHERAPY; MASAOKA STAGE; MULTIDISCIPLINARY APPROACH;

D O I：

10.6004/jnccn.2013.0072

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Masses in the anterior mediastinum can be neoplasms (eg, thymomas, thymic carcinomas, or lung metastases) or non-neoplastic conditions (eg, intrathoracic goiter). Thymomas are the most common primary tumor in the anterior mediastinum, although they are rare. Thymic carcinomas are very rare. Thymomas and thymic carcinomas originate in the thymus. Although thymomas can spread locally, they are much less invasive than thymic carcinomas. Patients with thymomas have 5-year survival rates of approximately 78%. However, 5-year survival rates for thymic carcinomas are only approximately 40%. These guidelines outline the evaluation, treatment, and management of these mediastinal tumors.

引用

页码：562 / 576

页数：15

共 129 条

[51] A single institutional experience of thymic epithelial tumours over 11 years: clinical features and outcome and implications for future management
Lee, H-S
Kim, S. T.
Lee, J.
Choi, Y. S.
Han, J-H
Ahn, Y-C
Lee, K-S
Ahn, J. S.
Ahn, M. J.
Kim, K.
Shim, Y. M.
Kim, J.
Park, K.
[J]. BRITISH JOURNAL OF CANCER, 2007, 97 (01) : 22 - 28
[52] Lemma GL, 2008, J CLIN ONCOL, V26
[53] Phase II Study of Carboplatin and Paclitaxel in Advanced Thymoma and Thymic Carcinoma
Lemma, Girum L.
Lee, Ju-Whei
Aisner, Seena C.
Langer, Corey J.
Tester, William J.
Johnson, David H.
Loehrer, Patrick J., Sr.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15) : 2060 - 2065
[54] LEWIS JE, 1987, CANCER-AM CANCER SOC, V60, P2727, DOI 10.1002/1097-0142(19871201)60:11<2727::AID-CNCR2820601125>3.0.CO
[55] 2-D
[56] Minimally Invasive and Robotic-Assisted Thymus Resection
Limmer, Karl K.
Kernstine, Kemp H.
[J]. THORACIC SURGERY CLINICS, 2011, 21 (01) : 69 - +
[57] CISPLATIN PLUS DOXORUBICIN PLUS CYCLOPHOSPHAMIDE IN METASTATIC OR RECURRENT THYMOMA - FINAL RESULTS OF AN INTERGROUP TRIAL
LOEHRER, PJ
KIM, K
AISNER, SC
LIVINGSTON, R
EINHORN, LH
JOHNSON, D
BLUM, R
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (06) : 1164 - 1168
[58] Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: An Eastern Cooperative Oncology Group phase II trial
Loehrer, PJ
Wang, W
Johnson, DH
Ettinger, DS
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (02) : 293 - 299
[59] Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: An intergroup trial
Loehrer, PJ
Chen, M
Kim, KM
Aisner, SC
Einhorn, LH
Livingston, R
Johnson, D
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (09) : 3093 - 3099
[60] Loehrer PJ, 2001, CANCER-AM CANCER SOC, V91, P2010, DOI 10.1002/1097-0142(20010601)91:11<2010::AID-CNCR1226>3.0.CO

← 1 2 3 4 5 6 7 8 9 10 →